JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONN
2001
DELISTED
Conn's Inc.
CONN
| $10.5M | ﹤0.01% |
296,692
+133,620
| +82% | +$4.08M |
|
2002
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
| $10.5M | ﹤0.01% |
501,285
+27,010
| +6% | +$561K |
|
|
LNW
2003
DELISTED
Light & Wonder
LNW
| $10.5M | ﹤0.01% |
204,426
+103,977
| +104% | +$5.07M |
|
|
AXAS
2004
DELISTED
Abraxas Petroleum Corp
AXAS
| $10.5M | ﹤0.01% |
212,912
-2,122
| -1% | -$88.1K |
|
2005
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $10.5M | ﹤0.01% |
327,140
+229,656
| +236% | +$7.08M |
|
2006
PUT
Texas Instruments
TXN
$257B
| $10.5M | ﹤0.01% |
100,300
+11,100
| +12% | +$1.08M |
|
|
FFIC
2007
DELISTED
Flushing Financial
FFIC
| $10.5M | ﹤0.01% |
380,122
-9,783
| -3% | -$282K |
|
2008
US Foods
USFD
$23.9B
| $10.4M | ﹤0.01% |
326,352
-6,409,528
| -95% | -$182M |
|
2009
PUT
Royal Caribbean
RCL
$82.1B
| $10.4M | ﹤0.01% |
87,200
+6,900
| +9% | +$854K |
|
|
SHPG
2010
PUT
DELISTED
Shire pic
SHPG
| $10.4M | ﹤0.01% |
67,000
+40,000
| +148% | +$5.93M |
|
|
EXPR
2011
DELISTED
Express, Inc.
EXPR
| $10.4M | ﹤0.01% |
51,095
+26,711
| +110% | +$4.38M |
|
|
MSCC
2012
DELISTED
Microsemi Corp
MSCC
| $10.3M | ﹤0.01% |
200,267
+37,697
| +23% | +$1.98M |
|
2013
Semtech
SMTC
$12.2B
| $10.3M | ﹤0.01% |
301,413
+67,023
| +29% | +$2.51M |
|
|
MDP
2014
DELISTED
Meredith Corporation
MDP
| $10.3M | ﹤0.01% |
155,557
+36,916
| +31% | +$2.23M |
|
2015
NewMarket
NEU
$8.43B
| $10.3M | ﹤0.01% |
25,815
+7,817
| +43% | +$3.17M |
|
2016
Annaly Capital Management
NLY
$17.4B
| $10.2M | ﹤0.01% |
215,075
+14,435
| +7% | +$685K |
|
|
SRG
2017
Seritage Growth Properties
SRG
$135M
| $10.2M | ﹤0.01% |
252,811
+142,032
| +128% | +$5.93M |
|
2018
Red Robin
RRGB
$145M
| $10.2M | ﹤0.01% |
181,278
+37,187
| +26% | +$2.14M |
|
|
AGN
2019
PUT
DELISTED
Allergan plc
AGN
| $10.2M | ﹤0.01% |
62,500
-61,600
| -50% | -$11.1M |
|
|
CHFN
2020
DELISTED
Charter Financial Corp
CHFN
| $10.2M | ﹤0.01% |
582,522
-24,131
| -4% | -$444K |
|
2021
CALL
Stanley Black & Decker
SWK
$15.7B
| $10.2M | ﹤0.01% |
60,200
+15,000
| +33% | +$2.46M |
|
2022
Itron
ITRI
$4.52B
| $10.2M | ﹤0.01% |
149,498
+62,083
| +71% | +$4.44M |
|
2023
CALL
Rogers Communications
RCI
$19.1B
| $10.2M | ﹤0.01% |
200,000
| – | – |
|
2024
Grupo Aeroportuario del Pacifico
PAC
$12.7B
| $10.2M | ﹤0.01% |
99,066
+40,746
| +70% | +$4.01M |
|
|
SLCA
2025
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $10.2M | ﹤0.01% |
312,678
-268,970
| -46% | -$8.57M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.